Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. This Department is a joint venture between the Medical Faculty, Lund University and the Hematology Clinic at Lund University Hospital.
The laboratory investigates the properties of blood stem cells and is developing cell and gene therapy for blood disorders. The development of cell and gene therapy is considered important for many genetic disorders and cancer, disorders that remain incurable at present. Within the laboratory, there are eight independent research groups that collaborate closely to understand the regulation of blood stem cells.
Six of these research groups are members of the Hemato Linné excellence program in blood stem cell biology (Linnaeus Program) funded by The Swedish Research Council and Lund University and several of the groups are also members of STEMTHERAPY, a strategic research and infrastructure program, also supported by The Swedish Research Council.
Researchers at Lund University have shed light on how and when the immune system is formed, raising hope of better understanding various diseases in children, such as leukaemia.
The immune system is complex and a number of genetic diseases are attributed to defects in the cells that form its origins. The study from Lund and Oxford University presents unique findings on the formation of these cells.
On October 16th, 2013, the Ragnar Söderberg foundation announced the Ragnar Söderbergs Scientist in Medicine for 2013. Johan Flygare was one of the six scientists who received the grant, 8 million SEK over 5 years, which will enable him to develop his project on anemia and red blood cell development.